Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation | Zendy

AI Assistant Blog Pricing

Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.